Scinai Immunotherapeutics Ltd. (SCNI) stock
SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.37−0.03 (-7.82%)
Close on Nov 17, 2026Market cap $1.29MP/E –Yield –
Scinai Immunotherapeutics gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2025 it was -202.3%, against -88.1% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -202.3% | −114.1 |
| FY2024 | Dec 31, 2024 | -88.1% | – |
See a number that looks wrong?